ArticleEuropean journal of haematology2021

The impact of COVID-19 in the management of AL amyloidosis and Immunoglobulin Deposition Disease: A single-center experience.

Holly Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.